GSK3B and breast carcinoma: miR-3646 has been reported to act as a potential oncogene in lung adenocarcinoma and breast cancer [40,41] and to contribute to docetaxel resistance in breast cancer cells by suppressing the GSK-3β/β-catenin signaling pathway [42].